ABVC BioPharma Statistics
NASDAQ: ABVCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8663-0.0137 (-1.56%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ABVC BioPharma by the numbers
ABVC BioPharma has a market capitalization of $23.4 million based on 26.98M shares outstanding. With trailing EPS of $-0.20, ABVC BioPharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.3% below its 50-day average and 26.5% below its 200-day average.
Average daily trading volume is 81.92K shares, or about $70,966 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABVC valuation vs. peer median
| Metric | ABVC | Peer median | Difference |
|---|---|---|---|
| Market cap | $23.37M | $23.51M | -1% |
| Avg. volume | 81.92K | 175.71K | -53% |
Peer median across 8 companies: SCYX, LITS, IXHL, RMTI, IMMP, CRVO, BCTX, TELO.
Valuation
- Market cap
- $23.37M
- Price / sales (latest FY)
- 78.95
- EPS (TTM)
- $-0.20
- Shares outstanding
- 26.98M
Price and trading
- Previous close
- 0.88
- Open
- 0.917
- Day range
- 0.85 – 0.917
- 52-week range
- 0.707 – 2.87
- 52-week change
- -67.80%
- Beta
- —
- Volume
- 39.05K
- Average volume
- 81.92K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 23.37M
- Forward Pe
- -1.97
- Eps
- -0.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.87
- Week52 Low
- 0.71
- Avg Volume
- 81,918.00
- Shares Outstanding
- 26.98M
- Ma50
- 1.01
- Ma200
- 1.18
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -69.82%
- Pct From52w Low
- 22.53%